Skip to main content

Lupus

    RT @KDAO2011: #ACR20 Dr. M. Crow on Lupus #StateofArtLecture reviews treatment of SLE:
    1. HCQ is the foundation of Rx
    2
    3 years 6 months ago
    #ACR20 Dr. M. Crow on Lupus #StateofArtLecture reviews treatment of SLE: 1. HCQ is the foundation of Rx 2. keep pred <7.5mg/day 3. belimumab works better when given early in disease (<2 yrs) 4. combination Rx may be needed @rheumnow https://t.co/6zh1xkLXgN
    Saturday was the day 2 with many posters and live sessions at the 2020 Virtual ACR/ARP meeting. Here are a few of my highlights from day two: Targeting Plasmacytoid Dendritic Cells in Lupus…
    RT @lexmeara: So much more work to be done- the traditional tools for estimating CVD in rheumatic patients are likely no
    3 years 6 months ago
    So much more work to be done- the traditional tools for estimating CVD in rheumatic patients are likely not accurate especially patients with SLE- abstract 1286 @RheumNow #acr20 https://t.co/L6Z1fsO2he
    RT @RichardPAConway: Dr @AliDuarteMD presents on incidence of SLE over last 40 years, 29% increase overall, and doubled
    3 years 6 months ago
    Dr @AliDuarteMD presents on incidence of SLE over last 40 years, 29% increase overall, and doubled in males. Overall cyclical pattern. Abstr#1024 #ACR20 @rheumnow https://t.co/SSVY0U0SIg
    HCQ and QTc in RA and SLE Patients: Dr. Kathryn Dao

    Dr. Kathryn Dao reviews abstract #0431 presented at the 2020 ACR annual meeting. 

    RT @bella_mehta: Another addition to "Where you live matters!" NYC principal component analysis of 140 neighborhood char
    3 years 6 months ago
    Another addition to "Where you live matters!" NYC principal component analysis of 140 neighborhood characteristics show - location and SES influence incidence and severity of #COVID19 in #SLE @rheumnow #ACR20 ABS#0984
    RT @drpnash: Toll-like Receptor Inhibitor Peptide Improves the Clinical, Immunologic, and Pathologic Manifestations of S
    3 years 6 months ago
    Toll-like Receptor Inhibitor Peptide Improves the Clinical, Immunologic, and Pathologic Manifestations of Systemic Lupus Erythematosus https://t.co/hAqngljp2b #sle #tollreceptorinhib TLR inhib in mice for SLE
    RT @DrPedsRheum: TMA and SLE by Dr Levy @SickKidsNews

    👉TMA triad - microangiopathic hemolytic anemia, thrombocytopen
    3 years 6 months ago
    TMA and SLE by Dr Levy @SickKidsNews 👉TMA triad - microangiopathic hemolytic anemia, thrombocytopenia, impaired renal function 👉TTP pentad - fever, thrombocytopenia, hemolytic anemia, renal impairment, neurologic involvement #ACR20 #ACRambassador https://t.co/xnO1JkhSFT
    RT @DrMiniDey: Neighbourhood characteristics &amp; socioeconomic factors important not only for contracting #COVID19 but
    3 years 6 months ago
    Neighbourhood characteristics & socioeconomic factors important not only for contracting #COVID19 but also severe infection in #SLE. Results useful for developing strategies to address socioeconomic stressors in this population. Abs#0984 #ACR20 @RheumNow https://t.co/u4YDcfEcSQ
    RT @DrMiniDey: Time-trend analysis in hospitalised #infection in #lupus
    -Incr. rate of hospitalised infections over time
    3 years 6 months ago
    Time-trend analysis in hospitalised #infection in #lupus -Incr. rate of hospitalised infections over time -#Sepsis surpassed #pneumonia as most common hospitalised infection in 2011-12; twice as many sepsis vs pneumonia by 2015-16 Abs#0980 #ACR20 @RheumNow https://t.co/M8xbMDFUTS https://t.co/ShogvxbhzN